Navigation Links
Cedars-Sinai awarded $17.8 million grant to develop ALS treatment
Date:7/27/2012

LOS ANGELES (July 26, 2012) Cedars-Sinai Regenerative Medicine Institute today was awarded a $17.8 million grant from the California Institute for Regenerative Medicine to develop stem cell treatments for patients with ALS, also known as Lou Gehrig's Disease, a progressive, fatal and currently incurable neurodegenerative disease.

The grant the largest to date from the stem cell agency to Cedars-Sinai -- will fund a project with combined stem cell and gene therapy to treat amyotrophic lateral sclerosis with stem cells found in early brain development and a protein called GDNF that promotes the survival of neurons. The stem cells alone have the potential to protect damaged motor neurons in ALS. This potential increases when combined with the additional known effects of GDNF. In the past, delivering GDNF to the brain or spinal cord has been nearly impossible because it does not cross from the blood to the tissue of the spinal cord.

"We're looking at a novel and exciting way of using stem cells as 'Trojan horses' that arrive at the sick motor neurons and delivers the protein exactly where it's needed," Clive Svendsen, PhD, director of the Regenerative Medicine Institute and leader of the project,. "Our early study indicates this approach has significant potential and we're excited to bring this treatment a step closer to helping ALS patients."

About 30,000 patients in the United States have ALS, which affects nerve cells in the brain and the spinal cord. Motor neurons connect the brain to the spinal cord and then to the muscles throughout the body. Degeneration of these motor neurons is eventually fatal to ALS patients. As the motor neurons die, the brain loses the ability to initiate and control muscle movement. Patients in later stages of the disease become paralyzed.

"For the thousands living with ALS, there is no therapy now that can cure or slow their disease," said Shlomo Melmed, MD, senior vice president of Academic Affairs, dean of the Medical Faculty and Helene A. and Philip E. Hixon Chair in Investigative Medicine. "We're grateful that this grant will allow us to vigorously pursue novel therapies and benefit ALS patients."

The Cedars-Sinai proposal involves collaborations with Emory University in Atlanta and California Pacific Medical Center, bringing together teams of scientists, neurologists, neurosurgeons and nurses to take the stem cells from animal studies, through the regulatory process of FDA approval and into an 18-patient clinical trial for ALS in four years.

Svendsen expressed his thanks to Sheryl Osborne, a San Diego-based consultant, as well as their collaborators and his research team at Cedars-Sinai.

"I am grateful for the dedication our team has shown to ALS," Svendsen said. "We have a hard road ahead, and everyone should be humbled by the aggressiveness of this devastating disease. This combined gene and cell therapy approach may be one hope to fight back. With this CIRM funding, we can now move the study forward."

The Cedars-Sinai team was among seven to receive grants today from the California state stem cell agency. The current round of $150 million in new funding is to advance projects that represent the best possible chance of producing therapies for deadly and disabling diseases and disorders. The California Institute for Regenerative Medicine was established in November 2004 with passage of Proposition 71, the California Stem Cell Research and Cures Act, providing $3 billion in funding for stem cell research at universities and research institutions. CIRM previously awarded eight grants to Cedars-Sinai for a total of $11.1 million.


'/>"/>
Contact: Nicole White
nicole.white@cshs.org
310-423-5215
Cedars-Sinai Medical Center
Source:Eurekalert  

Related medicine news :

1. Cedars-Sinai stroke team earns award for improving regions quality of care
2. Cedars-Sinai physician definitively links irritable bowel syndrome and bacteria in gut
3. Cedars-Sinai researchers, with stem cells, advance understanding of spinal muscular atrophy
4. Cedars-Sinai Medical Center studies galaxy-exploring camera in the operating room
5. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
6. $9 million grant awarded to UH to study, treat learning disabilities
7. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
8. Moffitt researcher awarded GE grant to develop tool to detect breast cancer metastasis genetic risks
9. Grant awarded to help improve problem-solving skills for deaf and hard-of-hearing students
10. Southeast program to fight diabetes awarded nearly $10 million by HHS
11. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cedars-Sinai awarded $17.8 million grant to develop ALS treatment
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: